Voyager Therapeutics, Inc. (NASDAQ:VYGR) recent rally took place on significantly less volume which dipped to nearly 268094 contracts on 24-May-19 versus its daily average of 269040. The first sale was made at $23.08 but later the stock became weaker, and closed with a gain of 5.56%. It was last traded at $24.12 apiece.Voyager Therapeutics, Inc. (VYGR): Outperform Candidate With 8.5% Upside Potential
Voyager Therapeutics, Inc. is maintained at an average outperform rating by 12 stock analysts, and there are at least 5.44% of shares outstanding that are currently legally short sold. The shares went up by 14.15% in value last month. Year-to-date it jumped 156.6%. Analysts are turning out to be more optimistic than before, with 9 of analysts who cover Voyager Therapeutics, Inc. (NASDAQ:VYGR) advice adding it to buy candidate list. Wall Street experts also assign a $26.17 price target on Voyager Therapeutics, Inc., pointing towards a 8.5% rally from current levels. The stock is trading for about -6.29% less than its 52-week high.
Voyager Therapeutics, Inc. (VYGR) remained unsuccessful in beating the consensus-estimated $0.58 as it actually earned -$0.81 per share in its last reported financial results. Revenue, on the other hand, scored 2301.99% growth from the previous quarter, coming up with $48.28 million.VYGR Adds 8.89% In A Week
This company shares (VYGR) so far managed to recover 210.82% since collapsing to its 52-week low. Over a week, it has seen its stock price volatility to stay at 5.66% while widening the period to a month, volatility was 6.26%. The share price has already crossed its 20 days moving average, floating at a distance of 5.66% and sits 14.65% higher versus its 50 days moving average. When looking at the past five sessions, the stock returned 8.89% gains and is up by 52.31% compared with its 200-day moving average of $15.02. Also, Voyager Therapeutics, Inc. (VYGR) needs to expand a 27.35% increase it experienced over the past twelve months.
As regular trading ended, Dynavax Technologies Corporation (DVAX) stock brought in a -$0.57 drop to $5.78. The day started at a price of $6.44 but then traded as high as $6.92 before giving part of the gains back. As for this week, analysts appear content to stick with their bright outlook with the consensus call at 1.8. Dynavax Technologies Corporation is given 1 buy-equivalent recommendations, 0 sells and 0 holds. The company shares sank -66.1% from their peak of $17.05 and now has a $413.21 million market value of equity.Dynavax Technologies Corporation Could Grow 414.71% More
DVAX’s mean recommendation on Reuter’s scale improved from 1.8 thirty days ago to 1.83 now, which indicates a buy consensus from the analyst community. They see Dynavax Technologies Corporation (DVAX) price hitting a mean target of $29.75 a share, meaning the stock still has potential that could lift the price another 414.71% . Also, the recent close suggests the stock is underpriced by 419.03% compared to the most bullish target.
The company had seen its current volume reaching at 5270363 shares in the last trade. That compares with the recent volume average of 1803500. At the close of regular trading, its last week’s stock price volatility was 8.03% which for the month reaches 12.38%. Dynavax Technologies Corporation dipped to as low as $5.12 throughout the day and has returned -36.83% in this year. At one point in the past year, the shares traded as low as $5.89 but has recovered -1.78% since then. [T4]